Literature DB >> 29262283

Signatures of DNA-Repair Deficiencies in Breast Cancer.

Nicholas C Turner1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29262283     DOI： 10.1056/NEJMcibr1710161

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  DrABC: deep learning accurately predicts germline pathogenic mutation status in breast cancer patients based on phenotype data.

Authors:  Jiaqi Liu; Hengqiang Zhao; Yu Zheng; Lin Dong; Sen Zhao; Yongxin Yang; Zhihong Wu; Zhihua Liu; Jianming Ying; Xin Wang; Yukuan Huang; Shengkai Huang; Tianyi Qian; Jiali Zou; Shu Liu; Jun Li; Zihui Yan; Yalun Li; Shuo Zhang; Xin Huang; Wenyan Wang; Yiqun Li; Jie Wang; Yue Ming; Xiaoxin Li; Zeyu Xing; Ling Qin; Zhengye Zhao; Ziqi Jia; Jiaxin Li; Gang Liu; Menglu Zhang; Kexin Feng; Jiang Wu; Jianguo Zhang; Jianzhong Su; Xiang Wang; Nan Wu
Journal:  Genome Med       Date:  2022-02-25       Impact factor: 11.117

2.  Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer.

Authors:  Neha Chopra; Holly Tovey; Alex Pearson; Ros Cutts; Christy Toms; Paula Proszek; Michael Hubank; Mitch Dowsett; Andrew Dodson; Frances Daley; Divya Kriplani; Heidi Gevensleben; Helen Ruth Davies; Andrea Degasperi; Rebecca Roylance; Stephen Chan; Andrew Tutt; Anthony Skene; Abigail Evans; Judith M Bliss; Serena Nik-Zainal; Nicholas C Turner
Journal:  Nat Commun       Date:  2020-05-29       Impact factor: 14.919

Review 3.  Breast Cancer Heterogeneity and Response to Novel Therapeutics.

Authors:  Mariona Baliu-Piqué; Atanasio Pandiella; Alberto Ocana
Journal:  Cancers (Basel)       Date:  2020-11-05       Impact factor: 6.639

4.  2-Hydroxyglutarate destabilizes chromatin regulatory landscape and lineage fidelity to promote cellular heterogeneity.

Authors:  Meena Kusi; Maryam Zand; Li-Ling Lin; Meizhen Chen; Anthony Lopez; Chun-Lin Lin; Chiou-Miin Wang; Nicholas D Lucio; Nameer B Kirma; Jianhua Ruan; Tim H-M Huang; Kohzoh Mitsuya
Journal:  Cell Rep       Date:  2022-01-11       Impact factor: 9.423

Review 5.  Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications.

Authors:  Karama Asleh; Nazia Riaz; Torsten O Nielsen
Journal:  J Exp Clin Cancer Res       Date:  2022-09-01

Review 6.  Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies.

Authors:  Smarakan Sneha; Simon C Baker; Andrew Green; Sarah Storr; Radhika Aiyappa; Stewart Martin; Klaus Pors
Journal:  Biomedicines       Date:  2021-03-12

7.  RAD51-Mediated DNA Homologous Recombination Is Independent of PTEN Mutational Status.

Authors:  Asha Sinha; Ali Saleh; Raelene Endersby; Shek H Yuan; Chirayu R Chokshi; Kevin R Brown; Bozena Kuzio; Tiina Kauppinen; Sheila K Singh; Suzanne J Baker; Peter J McKinnon; Sachin Katyal
Journal:  Cancers (Basel)       Date:  2020-10-29       Impact factor: 6.575

8.  The Distinct Performances of Ultrasound, Mammograms, and MRI in Detecting Breast Cancer in Patients With Germline Pathogenic Variants in Cancer Predisposition Genes.

Authors:  Jiaqi Liu; Xin Wang; Lin Dong; Xin Huang; Hengqiang Zhao; Jiaxin Li; Shengkai Huang; Pei Yuan; Wenyan Wang; Jie Wang; Zeyu Xing; Ziqi Jia; Yue Ming; Xiao Li; Ling Qin; Gang Liu; Jiang Wu; Yiqun Li; Menglu Zhang; Kexin Feng; Jianming Ying; Xiang Wang
Journal:  Front Oncol       Date:  2021-07-13       Impact factor: 6.244
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.